Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Wed, 11/14/18 - 11:45 pm
Pfizer
biosimilars
Amgen
Epogen
JNJ
Procrit
anemia
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health
BioSpace
Wed, 11/14/18 - 09:56 am
Viagra
Pfizer
Cialis
Eli Lilly
erectile dysfunction
cancer
Cardiovascular
drug repurposing
Concert’s initial alopecia data fall short against Pfizer, prompting investor blow back
Endpoints
Tue, 11/13/18 - 09:50 am
Concert Pharmaceuticals
alopecia
JAK inhibitors
Pfizer
CTP-543
Pfizer's PARP, androgen inhibitors next combo partners for NKTR-214
BioCentury
Tue, 11/6/18 - 11:35 am
Pfizer
Nektar Therapeutics
NKTR-214
Xtandi
Talzenna
Bavencio
prostate cancer
Mylan and Pfizer report new issues affecting some EpiPens that can delay treatment
Fierce Pharma
Sat, 11/3/18 - 04:12 pm
Mylan Labs
Pfizer
EpiPens
FDA approves Pfizer's treatment for certain lung cancer patients
Yahoo/Reuters
Sat, 11/3/18 - 12:33 pm
Pfizer
FDA
Lorbrena
ALK-positive non-small cell lung cancer
NASH Treatment: Will a Combo Drug Developed by Novartis and Pfizer Make the Cut?
Xtalks
Thu, 11/1/18 - 07:13 pm
Pfizer
Novartis
NASH
Pfizer likely to remove lid on drug price increases in January
BioCentury
Tue, 10/30/18 - 11:20 pm
Pfizer
drug prices
Pharma CEOs
Ian Read
Pfizer's 3Q profit, up due to tax cut, beats expectations
Yahoo/AP
Tue, 10/30/18 - 07:05 pm
Pfizer
earnings
tax cuts
Big Pharma rivals Pfizer and Novartis team up on NASH combo targets
Fierce Biotech
Mon, 10/29/18 - 11:50 am
Pfizer
Novartis
NASH
drug development
This Big Pharma Bet Isn't Paying Off Yet
Motley Fool
Sun, 10/28/18 - 07:42 pm
Big Pharma
biosimilars
Novartis
Amgen
Merck
Pfizer
Biogen
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Pfizer works to get 'wait-and-see' doctors on board the Ibrance train
Fierce Pharma
Fri, 10/26/18 - 11:55 am
Pfizer
Ibrance
physicians
breast cancer
Daiichi Sankyo signs clinical trial collaboration deal with Merck and Pfizer
Pharmaceutical Business Review
Fri, 10/26/18 - 09:52 am
Daiichi Sankyo
Merck
Pfizer
clinical trials
DS-8201
solid tumors
Bayer plans filings for prostate cancer drug darolutamide
Pharmaforum
Wed, 10/24/18 - 10:09 am
Bayer
darolutamide
prostate cancer
Pfizer
JNJ
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
Yahoo/Reuters
Tue, 10/23/18 - 11:09 pm
Pfizer
Eli Lilly
osteoarthritis
opioid alternatives
painkillers
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
CP Wire
Tue, 10/23/18 - 01:57 pm
Bain Capital
Pfizer
Cerevel Therapeutics
CNS
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
Tue, 10/23/18 - 05:30 pm
Pfizer
Bain Capital
Cerevel Therapeutics
Pfizer preps for BMS showdown with Bavencio kidney cancer combo data
Fierce Pharma
Sun, 10/21/18 - 11:28 pm
Pfizer
Bristol-Myers Squibb
kidney cancer
Bavencio
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
Fierce Pharma
Sat, 10/20/18 - 10:37 pm
Lilly
Verzenio
breast cancer
Pfizer
Ibrance
Novartis
Kisqali
NICE
Pages
« first
‹ previous
…
91
92
93
94
95
96
97
98
99
…
next ›
last »